Wanqiu Yang1,2, Miao Qu3, Rui Jiang4, XiaoE Lang5, Xiang-Yang Zhang6,7. 1. School of Ethnology and Sociology, Yunnan University, Kunming, China. 2. The Mental Health Center, Yunnan University, Kunming, China. 3. Neurology Department, Xuan Wu Hospital of Capital Medical University, Beijing, China. 4. Qingdao Mental Health Center, Qingdao University, Qingdao, China. 5. Department of Psychiatry, First Hospital/First Clinical Medical College of Shanxi Medical University, Taiyuan, China. 6. CAS Key Laboratory of Mental Health, Institute of Psychology, Chinese Academy of Sciences, 16 Lincui Road, Chaoyang District, Beijing, 100101, China. zhangxy@psych.ac.cn. 7. Department of Psychology, University of Chinese Academy of Sciences, Beijing, China. zhangxy@psych.ac.cn.
Abstract
OBJECTIVE: Existing studies have shown that thyroid dysfunction is associated with depression. However, its role in major depressive disorder (MDD) with comorbid anxiety remains unclear. The main purpose of this study was to compare thyroid function in a large sample of first episode drug naïve (FEDN) MDD patients with and without anxiety. METHODS: This cross-sectional study examined 1718 outpatients who were drug-naïve and diagnosed as MDD at first episode. Socio-demographic and clinical data, as well as thyroid function-related parameters, including free thyroxine (FT4), free triiodothyronine (FT3), thyroid-stimulating hormone (TSH), thyroid peroxidase antibodies (TPOAb) and anti-thyroglobulin (TGAb), were evaluated. The Hamilton Depression Rating Scale (HAMD), Hamilton Anxiety Rating Scale (HAMA) and the positive subscale of the Positive and Negative Syndrome Scale (PANSS) were used to evaluate depressive, anxiety and psychotic symptoms, respectively. RESULTS: Compared to MDD patients without anxiety, MDD patients with anxiety were more likely to have more suicide attempts and psychotic symptoms, as well as higher serum levels of TSH, TPOAb and TGAb (all p < 0.001). Among patients with abnormally elevated serum TSH, TPOAb, and TGAb, 83.5% (872/1044), 89.3% (391/438) and 89.6% (266/297) had comorbid anxiety disorders, respectively. The odds ratio between patients with comorbid and without comorbid anxiety was 1.657 (95% CI 1.304-2.105) for elevated TSH levels, 1.943 (95% CI 1.444-2.613) for elevated TGAb levels, and 2.448 (95% CI 1.760-3.403) for elevated TPOAb levels. Furthermore, multivariable linear analysis showed that elevated TSH and TGAb were significant predictors of anxiety in MDD patients. CONCLUSIONS: Our results suggest that comorbid anxiety in FEDN MDD patients is positively associated with elevated TSH and TGAb levels, which may be promising biomarkers of comorbid anxiety in MDD patients. Clinical treatment of impaired thyroid function may be useful for comorbid anxiety in MDD patients.
OBJECTIVE: Existing studies have shown that thyroid dysfunction is associated with depression. However, its role in major depressive disorder (MDD) with comorbid anxiety remains unclear. The main purpose of this study was to compare thyroid function in a large sample of first episode drug naïve (FEDN) MDD patients with and without anxiety. METHODS: This cross-sectional study examined 1718 outpatients who were drug-naïve and diagnosed as MDD at first episode. Socio-demographic and clinical data, as well as thyroid function-related parameters, including free thyroxine (FT4), free triiodothyronine (FT3), thyroid-stimulating hormone (TSH), thyroid peroxidase antibodies (TPOAb) and anti-thyroglobulin (TGAb), were evaluated. The Hamilton Depression Rating Scale (HAMD), Hamilton Anxiety Rating Scale (HAMA) and the positive subscale of the Positive and Negative Syndrome Scale (PANSS) were used to evaluate depressive, anxiety and psychotic symptoms, respectively. RESULTS: Compared to MDD patients without anxiety, MDD patients with anxiety were more likely to have more suicide attempts and psychotic symptoms, as well as higher serum levels of TSH, TPOAb and TGAb (all p < 0.001). Among patients with abnormally elevated serum TSH, TPOAb, and TGAb, 83.5% (872/1044), 89.3% (391/438) and 89.6% (266/297) had comorbid anxiety disorders, respectively. The odds ratio between patients with comorbid and without comorbid anxiety was 1.657 (95% CI 1.304-2.105) for elevated TSH levels, 1.943 (95% CI 1.444-2.613) for elevated TGAb levels, and 2.448 (95% CI 1.760-3.403) for elevated TPOAb levels. Furthermore, multivariable linear analysis showed that elevated TSH and TGAb were significant predictors of anxiety in MDD patients. CONCLUSIONS: Our results suggest that comorbid anxiety in FEDN MDD patients is positively associated with elevated TSH and TGAb levels, which may be promising biomarkers of comorbid anxiety in MDD patients. Clinical treatment of impaired thyroid function may be useful for comorbid anxiety in MDD patients.
Authors: Katja Wiethoff; Michael Bauer; Thomas C Baghai; Hans-Jürgen Möller; Robert Fisher; Dorothea Hollinde; Julia Kiermeir; Iris Hauth; Gerd Laux; Joachim Cordes; Peter Brieger; Klaus-Thomas Kronmüller; Joachim Zeiler; Mazda Adli Journal: J Clin Psychiatry Date: 2010-07-13 Impact factor: 4.384
Authors: Arjan W Braam; John R M Copeland; Philippe A E G Delespaul; Aartjan T F Beekman; Ariel Como; Michael Dewey; Manfred Fichter; Tjalling J Holwerda; Brian A Lawlor; Antonio Lobo; Hallgrímur Magnússon; Martin J Prince; Friedel Reischies; Kenneth C Wilson; Ingmar Skoog Journal: J Affect Disord Date: 2013-11-25 Impact factor: 4.839
Authors: Jill M Cyranowski; Laura L Schott; Howard M Kravitz; Charlotte Brown; Rebecca C Thurston; Hadine Joffe; Karen A Matthews; Joyce T Bromberger Journal: Depress Anxiety Date: 2012-08-28 Impact factor: 6.505
Authors: Pierre M Bet; Jacqueline G Hugtenburg; Brenda W J H Penninx; Anton van Balkom; Willem A Nolen; Witte J G Hoogendijk Journal: Psychiatry Res Date: 2013-07-11 Impact factor: 3.222
Authors: Jantien P Brouwer; Bente C Appelhof; Witte J G Hoogendijk; Jochanan Huyser; Erik Endert; Cassandra Zuketto; Aart H Schene; Jan G P Tijssen; Richard Van Dyck; Wilmar M Wiersinga; Eric Fliers Journal: Eur J Endocrinol Date: 2005-02 Impact factor: 6.664